City
Epaper

Pharmacopoeia Commission conducts training programme to boost regulation, quality of Ayush drugs

By IANS | Updated: September 13, 2025 11:00 IST

New Delhi, Sep 13 The Pharmacopoeia Commission for Indian Medicine and Homoeopathy has conducted a Capacity-Building Training Programme ...

Open in App

New Delhi, Sep 13 The Pharmacopoeia Commission for Indian Medicine and Homoeopathy has conducted a Capacity-Building Training Programme to enhance regulation and quality of Ayush drugs, the Ministry of Ayush said.

The five-day programme, held from September 8 to 12 in Ghaziabad, aimed to strengthen the regulatory framework, quality assurance, and standardisation processes for Ayurveda, Siddha, Unani, and Homoeopathy drugs.

The training brought together 27 participants from across India, representing regulatory bodies, research councils, pharmaceutical industries, and academic institutions.

The comprehensive sessions were designed to equip Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers with advanced knowledge and hands-on experience in pharmacopoeial standards and Good Manufacturing Practices (GMP).

The technical sessions covered pharmacognostic identification, phytochemical analysis, and GMP compliance, along with hands-on training in the pharmacognosy and chemistry laboratories.

The lectures by several experts focused on shelf-life studies and regulatory frameworks, followed by industry visits to Dr. Willmar Schwabe India (Noida) and Hamdard Laboratories (Ghaziabad), offering real-world exposure.

The sessions included microbiological and pharmacological evaluations, standardisation of metal and mineral drugs, and regulatory aspects. Participants also engaged in laboratory training and visited the on-site herbal garden.

The sessions also featured discussions on NABL accreditation, GMP, and the standardisation of Siddha drugs.

Participants highly appreciated the programme’s unique blend of expert-led lectures, practical laboratory sessions, and field visits.

The training significantly contributed to enhancing their understanding of pharmacopoeial standards, GMP, and regulatory compliance, thereby reinforcing the national commitment to ensuring the safety, efficacy, and quality of ASU&H drugs.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Politics"He is using abusive language in public": Congress leader Bhupesh Baghel slams Assam CM

Cricket"Fascinating to see the way he played": MI skipper Hardik hails Sooryavanshi after loss to RR

NationalWest Bengal Polls: "Manifesto unveiled keeping in mind opinions of people", says Congress leader Ghulam Ahmad Mir

Politics"Engaged in corruption, eviction notices": Congress leader Kanhaiya Kumar slams CM Himanta Biswa

InternationalIran agrees to cease military op for 2 weeks, allow safe passage via Hormuz after US accepts 10 point proposal

Health Realted Stories

HealthRajasthan govt deploys over 3,600 teams after child deaths in Salumber

HealthSC to hear PIL challenging reduction in qualifying percentiles for NEET-PG on April 28

HealthTelangana govt makes cancer notifiable for reliable data

HealthChhattisgarh: African Swine Fever outbreak confirmed, 300 pigs culled

HealthDelhi HC Court strikes down FSSAI regulation on cattle feed as ultra vires